Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report
Remap-Cap Investigators, AC Gordon, PR Mouncey… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
[HTML][HTML] Trial of early, goal-directed resuscitation for septic shock
PR Mouncey, TM Osborn, GS Power… - … England Journal of …, 2015 - Mass Medical Soc
Background Early, goal-directed therapy (EGDT) is recommended in international guidelines
for the resuscitation of patients presenting with early septic shock. However, adoption has …
for the resuscitation of patients presenting with early septic shock. However, adoption has …
[HTML][HTML] Restriction of intravenous fluid in ICU patients with septic shock
…, DW Gould, KM Rowan, PR Mouncey… - … England Journal of …, 2022 - Mass Medical Soc
Background Intravenous fluids are recommended for the treatment of patients who are in
septic shock, but higher fluid volumes have been associated with harm in patients who are in …
septic shock, but higher fluid volumes have been associated with harm in patients who are in …
Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial
…, C Whitman, JD Young, KM Rowan, PR Mouncey… - Jama, 2020 - jamanetwork.com
Importance Vasopressors are commonly administered to intensive care unit (ICU) patients
to raise blood pressure. Balancing risks and benefits of vasopressors is a challenge, …
to raise blood pressure. Balancing risks and benefits of vasopressors is a challenge, …
Trends in intensive care for patients with COVID-19 in England, Wales, and Northern Ireland
…, P Ferrando-Vivas, PR Mouncey… - American journal of …, 2021 - atsjournals.org
Rationale: By describing trends in intensive care for patients with coronavirus disease (COVID-19)
we aim to support clinical learning, service planning, and hypothesis generation. …
we aim to support clinical learning, service planning, and hypothesis generation. …
[HTML][HTML] COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland
…, DW Gould, K Thomas, JC Doidge, PR Mouncey… - Intensive care …, 2020 - Springer
Purpose To describe critical care patients with COVID-19 across England, Wales and Northern
Ireland and compare them with a historic cohort of patients with other viral pneumonias (…
Ireland and compare them with a historic cohort of patients with other viral pneumonias (…
[HTML][HTML] Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
…, SC Morpeth, PR Mouncey, K Orr, R Parke… - Intensive care …, 2021 - Springer
Purpose To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID-19 …
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID-19 …
[HTML][HTML] Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical …
…, SC Morpeth, PR Mouncey… - BMC infectious …, 2021 - Springer
Background Convalescent plasma has been widely used to treat COVID-19 and is under
investigation in numerous randomized clinical trials, but results are publicly available only for a …
investigation in numerous randomized clinical trials, but results are publicly available only for a …
Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive …
…, CJ McArthur, SP McGuinness, PR Mouncey… - Jama, 2020 - jamanetwork.com
Importance Proton pump inhibitors (PPIs) or histamine-2 receptor blockers (H 2 RBs) are
often prescribed for patients as stress ulcer prophylaxis drugs in the intensive care unit (ICU). …
often prescribed for patients as stress ulcer prophylaxis drugs in the intensive care unit (ICU). …
Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed …
PR Mouncey, TM Osborn… - Health technology …, 2015 - researchonline.lshtm.ac.uk
BACKGROUND: Early goal-directed therapy (EGDT) is recommended in international
guidance for the resuscitation of patients presenting with early septic shock. However, adoption …
guidance for the resuscitation of patients presenting with early septic shock. However, adoption …